Maeve McNally Email

Director Project Management . Tokai Pharmaceuticals

Current Roles

Employees:
44
Revenue:
$6.8M
About
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. Our lead program, AT-1501, is a potential best-in-class humanized IgG1 anti-CD40L antibody with high affinity for CD40L, a well-validated biological target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.
Tokai Pharmaceuticals Address
19900 MacArthur Blvd
Irvine, CA
United States
Tokai Pharmaceuticals Email

Past Companies

Eledon Pharmaceuticals, Inc.Director Project Management
ALS Therapy Development InstituteDirector Clinical Operations